Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-22-067737
Filing Date
2022-10-31
Accepted
2022-10-31 17:13:58
Documents
2
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea167817-pre14a_pasithea.htm PRE 14A 203057
2 GRAPHIC image_001.jpg GRAPHIC 3659
  Complete submission text file 0001213900-22-067737.txt   209210
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40804 | Film No.: 221347060
SIC: 2834 Pharmaceutical Preparations